Background and Purpose: Hypertension is a multifactorial disease, manifested by
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| INTRODUCTION
Vascular inflammation plays a pivotal role in the development and progression of hypertension and atherosclerosis (Guzik et al., 2007; Mikolajczyk et al., 2016; Skiba et al., 2017) . Recent studies have shown the involvement of different leukocyte populations such as T-cells (Guzik et al., 2007; Mikolajczyk et al., 2016) , monocytes (Fujisawa et al., 2017; Wenzel et al., 2011) , macrophages (Chan et al., 2012; Moore et al., 2015) , dendritic cells (Kirabo et al., 2014) , and NK cells (Kossmann et al., 2013) in hypertension (Guzik, Skiba, Touyz, & Harrison, 2017) . Angiotensin II (Ang II) and other pro-hypertensive stimuli induce immune cell activation and infiltration to the adventitia and peri-adventitial fat (Guzik et al., 2007) . These cells can produce a number of pro-inflammatory cytokines and chemokines accelerating inflammation and contributing to vascular disease in hypertension (Guzik et al., 2007; Kusters, Lutgens, & Seijkens, 2018; Mikolajczyk et al., 2016) . While a myriad of antihypertensive agents is available (Nguyen, Dominguez, Nguyen, & Gullapalli, 2010) , only a few partially target these inflammatory mechanisms (Hermann & Ruschitzka, 2006) .
Current antihypertensive drugs, including those which target the Ang II system, are effective in controlling BP only in a subset of patients; however, they do not provide sufficient prevention of target organ damage in these individuals (Wright et al., 2002) . Therefore, a more comprehensive way of targeting the pathology of hypertension is required, rather than solely focusing on BP regulation (Williams et al., 2018 ). This indicates a need for targeting the pathomechanisms involved in target organ damage including endothelial dysfunction, oxidative stress, and inflammation. The combination of a current antihypertensive agent with an anti-inflammatory compound, which targets the immune system, would be more efficacious in preventing tissue damage. Suppression of vascular inflammation processes may inhibit or delay the progression of both hypertension and atherosclerosis.
While systemic immunomodulation using anti-cytokine treatment has recently been provided with an important proof-of-concept, it is imperative to identify novel agents that lack strong systemic immunosuppressive properties (Ridker et al., 2017) . Many natural compounds derived from plants have shown anti-inflammatory activity. The naturally occurring 1,2,3,4,6-penta-O-galloyl-β-D-glucose (PGG) is a polyphenolic compound highly enriched in Oenothera paradoxa (Jaszewska, Kosmider, Kiss, & Naruszewicz, 2009; Kiss, Derwinska, Dawidowska, & Naruszewicz, 2008; Kiss, Filipek, Czerwinska, & Naruszewicz, 2010) . PGG has a wide range of biological activities including anticancer, anti-diabetic, anti-inflammatory, anti-oxidative, anti-allergy, antiviral, and antibacterial effects (Cryan et al., 2013; Zhang, Li, Kim, Hagerman, & Lu, 2009) . Little is known about the effect of PGG on hypertension or vascular inflammation. However, PGG was shown to reverse cholesterol transport by influencing the expression of scavenger receptors, suggesting that this polyphenolic component may represent a novel candidate in the prevention and treatment of atherosclerosis in humans (Zhao, Haller, & Ritsch, 2015 of the seeds were dissolved in water (500 ml) and extracted with ethyl acetate (3 × 500 ml). Ethyl acetate fractions were dried under vacuum at 45°C (giving a residue of~10 g). The ethyl acetate extract was further fractionated on a polyamide column (5 cm × 8 cm; particle size
What is already known
• PGG has a wide range of biological activities including anti-cancer, anti-inflammatory, anti-oxidative effects.
• Little is known about the effect of PGG on hypertension or vascular inflammation.
What this study adds
• PGG is a candidate for targeting vascular inflammation and protecting from both oxidative stress and endothelial dysfunction
• PGG has direct effects on T cell activation and their perivascular recruitment;
What is the clinical significance
• Penta-O-galloyl-β-D-glucose may provide opportunities for the effective treatment of vascular inflammation in cardiovascular disease and hypertension 0.05-0.16 mm, Carl Roth, Germany) and eluted with acetone-water (7:3 [vol:vol] ). One hundred fractions (50 ml each) were collected and pooled into 1A-6A main fractions based on their polyphenolic profile.
PGG presence was monitored using HPLC. Fraction 5A (675 mg) was further subfractionated on a Toyopearl HW-40, fine grade column (2.5 cm × 35 cm; Tosoh, Japan) using methanol-water (7:3 [vol:vol]) and acetone-water (7:3 [vol:vol] ) as eluents. One hundred twenty fractions (10 ml each) were collected. Fractions 111-119 were separated again, eluted with acetone-water (4:6 [vol:vol] ) as eluent to obtain a compound of purity >95% (390 mg). Chromatograms of crude seed extract and isolated PGG are presented in Figure S1 . 146.63, 146.53, 146.50, 146.44, 146.34 (C-3, C-5), 141.00, 140.53, 140.48, 140.27, 140.14 (C-4), 121.00, 120.31, 120.17, 120.13, 119.62 (C-1), 110.63, 110.48, 110.42, 110.40, 110.35 (C-2, C-6) . 
| Characterization of PGG

| Animals
Male C57BL/6J (RRID:IMSR_JAX:000664, Bar Harbor, ME, USA) mice (n = 70) were obtained from Jackson Laboratory. Mice were housed in controlled 12-hr light/dark conditions at a constant temperature (21 ± 3°C) with ad libitum access to water and standard diet (rat and mouse no. 1 maintenance diet, Special Diet Services).
Twelve-week-old mice underwent either sham (buffer) or Ang II (490 ng·min −1 ·kg −1 s.c.) treatment for 14 days, using an osmotic minipump (Alzet Model 2002, Alzet Corporation, CA) as previously described (Mikolajczyk et al., 2016) . This model of experimental hypertension in C57BL/6 mice has been well characterized previously (Guzik et al., 2007) . Surgical procedures were performed under general anaesthesia by using isoflurane (3-5% for induction and 1.5-3% for maintenance of anaesthesia). PGG 10 mg·kg −1 was injected i.p. every 2 days, as previously described (Huh et al., 2005) 
| Assessment of intracellular cytokines
Splenocytes (1 × 10 6 ) were suspended in RPMI 1640 medium (Gibco, Life
Technologies, USA) with 10% FBS, 200-mM L-glutamine, and 5 mg ml 
| Assessment of T-cell activation markers in vitro
To (BD Biosciences). After being stained the cells were washed in PBS with 1% FBS and were collected using a BD FACSVerse™ flow cytometer.
| Detection of vascular superoxide production
Aortic segments were equilibrated in oxygenated Krebs-HEPES (in mM: ) from intact vessels was measured in buffer (2 ml) containing lucigenin at 37°C using FB12 Tube Luminometer (Tritertek Berthold) as previously described (Sagan et al., 2012; Siedlinski et al., 2017) . Superoxide production was expressed as RLU·s·mg −1 of dry weight as described before 
| Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Harding et al., 2018) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017) .
| Effect of PGG on immune cell infiltration into pVAT during Ang II-dependent hypertension
The effect of PGG on leukocyte infiltration into the perivascular tissue 
| Effect of PGG on the content of activated T-cells during Ang II-dependent hypertension
As we had previously identified that the RANTES-CCR5 axis is essential for activated T-cell recruitment in hypertension (Mikolajczyk et al., 2016) , we next studied the effects of PGG on the expression of CCR5 and activation status of infiltrating T-cells. Ang II-dependent hypertension was associated with an increased number of CCR5 positive (both CD4 + and CD8 + ) T-cells in pVAT (Figure 3a) . Additionally, the number of (Figure 3a ).
| PGG exhibits anti-inflammatory effects in vitro
To investigate the effect of PGG on T-cell activation in vitro, we cultured freshly isolated splenocytes on anti-CD3-coated plates in the absence or presence of PGG in the final concentration 20 μM.
After 20 hr of cell culture, we observed that addition of PGG to the splenocytes slightly reduced the percentage of CCR5 + CD3 + and CCR5 + CD4 + cells. In addition, the mean intensity of fluorescence for CCR5 was decreased within CD4 + T-cells (Table 1) . PGG also decreased the mean intensity of fluorescence for CD25 in both CD4 + and CD8 + T-cells but had no effect on the expression of hyaluronan receptor-CD44 (Table 1) , confirming possible direct effects of PGG on T-cell biology, which were observed in vivo.
However, PGG at a dose of 50 μM had no effect on RANTES (CCL5) mRNA expression but effectively decreased the level of chemokine (C-C motif) ligand 2 (CCL2; also referred to as MCP-1) mRNA in the line of fibroblasts SW872 differentiated to adipocytes 
| PGG inhibits chemokine expression in vivo
Next, we investigated the effect of PGG on chemokine expression in a mouse model of experimental hypertension. Fourteen days of administration of Ang II significantly increased the expression of MCP-1 and RANTES in both aorta and pVAT (Figure 3b ). We also observed increased expression of macrophage inflammatory protein 1 α (MIP-1α; also known as CCL3) in pVAT following Ang II infusion (Figure 3b) . Interestingly, the administration of PGG significantly decreased the expression of both MCP-1 in aorta and RANTES in pVAT (Figure 3b ) while not exerting statistically significant effects on the expression of MIP-1α and MIP-1β (also known as CCL4; Figure 3b ).
| Effect of PGG on T-cell cytokine production
Considering the ability of PGG to decrease the expression of some cell activation markers, we next investigated its effect on the production 
| DISCUSSION
As we are learning about the potential benefits of limiting vascular inflammation (Kusters et al., 2018; Ridker et al., 2017) , there is an urgent need to identify novel ways to target vascular inflammation and investigate their effects on cardiovascular parameters. PGG represents a promising candidate in the prevention and therapy of many inflammatory diseases, diabetes, and cancer (Zhang et al., 2009) . While numerous studies have focused on its antitumour activity in a number of pathologies, primarily through the induction of apoptosis of cancer cells, several key papers have suggested significant anti-inflammatory properties of PGG (Feldman et al., 2001; Kang et al., 2005; Kiss, Filipek, Zyzynska-Granica, & Naruszewicz, 2013; Wu & Gu, 2009 ). In the present study, we focused on specific effects of PGG on vascular inflammation, showing that it affects, in particular, cellular components of the inflammatory infiltrate and may also inhibit T-cell activation and recruitment to the vessel wall. This is important in the prevention of vascular damage as a consequence of hypertension, which we have used as a model system of vascular inflammation. In preliminary experiments, we observed that PGG decreased the number of T-cells in pVAT while having only a moderate effect on macrophages. For this reason, we have focused on characterization of T-cell subsets in more details. In addition, this direction of study follows our previous investigations showing the effect on T-cells on vascular function in hypertension (Mikolajczyk et al., 2016) , while macrophages were demonstrated to be more important in models of atherosclerosis .
Our studies are in line with previous reports of systemic antiinflammatory activity of PGG, which suppresses a number of pro-TABLE 1 Effect of PGG (20 μM) on the expression of selected receptors on T-cells inflammatory cytokines (such as TNF-α) from human peripheral blood mononuclear cells exposed to LPS (Feldman et al., 2001) . Through the suppression of TNF-α, PGG effectively protects from otherwise lethal doses of LPS challenge (Genfa et al., 2005) . PGG significantly reduced LPS-induced NO production in macrophages, decreased gene expression and production of iNOS in a dose-dependent manner Lee, Lee, & Mar, 2003) , and inhibited COX-2 activity in LPS-activated macrophages (Lee et al., 2003) as well as the activation of NF-κB ). In addition, PGG, inhibited gene expression and secretion of IL-8, a major mediator of acute neutrophil-mediated inflammation, and CCL-2, a major mediator of chronic macrophage-mediated inflammation in human monocytic U937 cells stimulated with phorbol myristate acetate (Oh et al., 2003) .
However, no studies to date have addressed the effect of this compound on vascular inflammation and cytokine production, particularly essential for the regulation of endothelial function. We have recently shown that IFN-γ produced by CD8 cells infiltrating pVAT appears to be particularly important in the regulation of vascular function in hypertension (Kossmann et al., 2013; Mikolajczyk et al., 2016) . This is essential because endothelial dysfunction precedes development of atherosclerosis and leads to the clinical complications of hypertension (Wilk et al., 2013) .
In the present study, we show for the first time that 20 μM of PGG While PGG supressed other markers of T-cell activation, it did not induce cell death in the examined T-cells.
Our findings are in line with recent studies by Kim et al. (2015) who observed that p.o. administration of PGG suppressed the production of T helper 2 (IL-4 and IL-13) and T helper 1 (IFN-γ) as well as proinflammatory cytokines such TNF-α and IL-6. However, this was not observed in the case of anti-inflammatory IL-10 in ovalbuminrestimulated splenocytes from ovalbumin-sensitized mice.
Interestingly, PGG selectively induced IL-10 production in serum related to regulatory T-cells (Kim et al., 2015) . Effects of PGG on macrophages are better characterized. PGG has been shown to suppress IL-1β, TNF-α, and IL-6 in LPS-stimulated peritoneal macrophages This effect was mediated by suppression of NF-κB and MAPK signalling pathways in a MyD88 adaptor protein-dependent manner (Jang, Hyam, Jeong, Han, & Kim, 2013 ).
Although we did not observe a decreased in vitro production of TNF-α after PGG administration in neither T-cells nor SW872-derived adipocytes, such an effect was evident in response to in vivo administration of PGG. PGG significantly reduced the number of CD8 + TNF + cells but had no effect on the content of CD4 + TNF + and
Previous studies have demonstrated an essential role of IL-17 in hypertensive vascular dysfunction (Madhur et al., 2010) ; (Saleh, Norlander, & Madhur, 2016) . Therefore, we investigated the effects of PGG on the expression of this cytokine upon activation. While we observed the suppression of IL-17 production across all T-cell subsets in vitro, it reached statistical significance only in
which is in line with the fact that these cells are the predominant source of IL-17 in hypertension (Caillon et al., 2017; Saleh et al., 2016) . In vivo study using an experimental model of Ang II-dependent hypertension confirmed that PGG also effectively inhibited the production of IL-17A by CD4 + and CD3
Interestingly, while we observed a number of vasoprotective effects in relation to vascular inflammation, endothelial dysfunction, and vascular oxidative stress, these effects were independent of BP regulation, as i.p. injection of PGG at a dose of 10 mg·kg −1 every 2 days did not attenuate Ang II-induced hypertension. There was, however, a modest trend towards a mild BP reduction in these mice. It is also important to note that we have only performed tail-cuff BP measurement, and the use of telemetry could result in a more sensitive effect. Lack of antihypertensive effect may also be linked to the model we used. Interestingly, PGG revealed a strong dose-dependent hypotensive effect, reducing the BP significantly in spontaneously hypertensive rats with infusion of angiotensin I (Liu et al., 2003) . However, in that study, the authors used a complex model of spontaneous hypertension (through the use of spontaneously hypertensive rats), which is more sophisticated than the model of Ang II-induced hypertension (Lin, Lee, Chan, & Tse, 2016; Liu et al., 2003) . It should be emphasized that in that study, the authors also investigated the acute effect of PGG preceded by an infusion of Ang I. In contrast, we focused on the chronic effects of PGG, which did not reduce BP response to Ang II in our study.
ROS plays an important role in the regulation of endothelial function (Radziwon-Balicka et al., 2017; Shafique et al., 2017; Tsai et al., 2017) . It is well known that PGG acts as a ROS scavenger (Viswanatha, Shylaja, & Mohan, 2013) . Moreover, recently published studies have revealed that PGG induced SOD activity in Caenorhabditis elegans and reduced intracellular ROS accumulation in a dose-dependent manner (Ahn et al., 2013) . Early studies on PGG have demonstrated that it can protect cells from oxidative stress via heme oxygenase-1 induction, indicating that the PGG can also act as an indirect antioxidant (Choi et al., 2002) . The effects of PGG on vascular function are important. Although they may be partially linked to the reduction of vascular inflammation, PGG may also have direct effects on the vasculature. Indeed, we observed a significant reduction of vascular oxidative stress by PGG, in line with the fact that tannins have antioxidant properties (Riedl & Hagerman, 2001; Viswanatha et al., 2013) in a number of cellular models (Abdelwahed et al., 2007; Okubo et al., 2000) .
It is likely that the effects on endothelial function are mediated in part by the direct antioxidant properties of PGG, leading to an increase of NO bioavailability and in part indirectly, by reducing perivascular inflammation. The latter mechanism is supported by our previous study showing that perivascular T-cell infiltration may stimulate both oxidative stress and endothelial function (Mikolajczyk et al., 2016) . In that study, we demonstrated that IFN-γ was pivotal in the induction of endothelial dysfunction (Mikolajczyk et al., 2016) .
Interestingly, PGG affected T-cell IFN-γ production to the largest extent in the present in vivo study. This possible pleiotropic effect may indicate that compounds such as PGG may target multiple mechanisms of vascular dysfunction and disease, which could make them particularly valuable in multifactorial diseases such as hypertension. We observed that PGG normalized ROS production but only modestly improved vascular function. However, in our study, we used lucigenin-enhanced chemiluminescence, which allows detection of superoxide anion production. It is known that other radicals (hydroxyl radical, lipid peroxyl radical, and alkoxyl radical) and other molecules including peroxynitrite, hypochlorous acid, and hydrogen peroxide have strong oxidant properties and can affect vascular function (Guzik et al., 2002) . Furthermore, Ang II and H 2 O 2 cause the phosphorylation of eNOS on Tyr657, attenuating NO production (Carnicer et al., 2017; Douglas et al., 2018; Loot, Schreiber, Fisslthaler, & Fleming, 2009 ). Finally, Ang II could cause an H4B deficiency leading to eNOS uncoupling, resulting in lower NO production. All factors mentioned above are likely to work in concert, leading to the impairment of endothelium-dependent vasodilatation in hypertensive animals.
We observed that in response to SNP, there was a rightward shift in Ang II-treated aortas. This was seen in both PGG and placebo groups. This phenomenon is common in vascular studies of aortas from Ang II-infused animals and was observed previously by our group as well as others (Itani et al., 2016; Madhur et al., 2010; Mikolajczyk et al., 2016; Siedlinski et al., 2017) and may be linked to the impaired sensitivity of vascular smooth muscle cells and soluble guanylyl cyclase to NO upon chronic Ang II infusion (Sorop et al., 2017) . Reduction of vascular oxidative stress and endothelial dysfunction may serve as important mechanisms in the reduction of vascular inflammation as both chemokines and adhesion molecules are redox sensitive. Indeed, in a recent study, PGG was shown to inhibit a number of proinflammatory mediators such as LTB4, IL-8, and myeloperoxidase in human neutrophils through the suppression of ROS, particularly O 2 − (Kiss et al., 2010) . PGG is also known to inhibit β2-integrin (CD11b) and L-selectin (CD62L) expression on leukocytes (Kiss et al., 2013) .
Our findings support and extend these observations, showing reduced expression of molecules critical for the development of perivascular inflammation including CCR5 and CD44. This resulted in significantly decreased total leukocyte and T-cell infiltration in pVAT.
Experiments performed by our group on a human line of SW872 fibroblasts differentiated to adipocytes revealed that PGG at a dose of 50 μM effectively decreased the level of CCL-2 mRNA while having no effect on RANTES expression. However, the administration of PGG 
